Allan Shaw, Director at Akari Therapeutics, holds 0.00 shares in Onconetix (Ticker: ONCO), holds 6.39K shares in Vivus (Ticker: VVUSQ), holds 33.53K shares in Akari Therapeutics (Ticker: AKTX). Most recently, Allan Shaw Bought ― shares of Onconetix on Aug 23, 2022 for an estimated value of 296.36.